tiprankstipranks
M K Proteins Limited (IN:MKPL)
:MKPL
India Market
Want to see IN:MKPL full AI Analyst Report?

M K Proteins Limited (MKPL) AI Stock Analysis

0 Followers

Top Page

IN:MKPL

M K Proteins Limited

(MKPL)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
₹5.00
▼(-27.43% Downside)
Action:Reiterated
Date:06/03/26
The score is primarily held back by weakened financial quality—sharp margin compression and inconsistent cash-flow conversion—despite improved leverage and a strong FY2026 revenue rebound. Technicals also lean weak (below major moving averages with negative MACD), while valuation appears somewhat demanding at ~27.7x earnings given the profitability and cash-flow risks.
Positive Factors
Revenue Rebound
A clear FY2026 revenue rebound signals recovering demand and improved commercial execution. Sustained top-line growth can help absorb fixed costs, restore operating leverage, and provide cash flow runway for maintenance or targeted investments, strengthening resilience over coming quarters.
Negative Factors
Margin Compression
Substantial margin erosion materially reduces the company's buffer against commodity input swings and price competition. Persistently thin gross and net margins limit internal capital for reinvestment, constrain profitability recovery, and make earnings highly sensitive to cost or pricing shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
A clear FY2026 revenue rebound signals recovering demand and improved commercial execution. Sustained top-line growth can help absorb fixed costs, restore operating leverage, and provide cash flow runway for maintenance or targeted investments, strengthening resilience over coming quarters.
Read all positive factors

M K Proteins Limited (MKPL) vs. iShares MSCI India ETF (INDA)

M K Proteins Limited Business Overview & Revenue Model

Company Description
M. K. Proteins Limited specializes in the production and commercial activities related to a range of refined vegetable oils and their associated derivatives. The company's diverse offerings include refined varieties such as rice bran, sunflower, c...
How the Company Makes Money
MKPL generates revenue by refining and selling edible oils, such as mustard oil, soybean oil, and palm oil. The company sources raw materials, including oilseeds and crude oil, which are then processed at its facilities into finished products. The...

M K Proteins Limited Financial Statement Overview

Summary
Revenue rebounded strongly in FY2026 (+17.7% YoY), and leverage has improved (debt-to-equity ~0.49). However, profitability compressed sharply (gross margin ~2.9%, net margin ~1.8%) and cash generation is a key weakness with inconsistent/negative operating cash flow in multiple years and modest free cash flow versus earnings.
Income Statement
55
Neutral
Balance Sheet
72
Positive
Cash Flow
34
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue3.25B3.83B2.68B2.46B3.15B2.56B
Gross Profit196.86M109.81M156.53M192.91M204.93M186.78M
EBITDA146.78M114.17M129.08M170.99M176.52M157.88M
Net Income94.29M68.29M83.97M112.12M109.35M101.84M
Balance Sheet
Total Assets0.001.31B1.31B962.46M1.03B861.48M
Cash, Cash Equivalents and Short-Term Investments338.00K4.38M338.00K923.24K624.84K66.62K
Total Debt0.00371.38M387.24M200.83M455.35M367.84M
Total Liabilities-694.66M548.97M611.04M351.70M533.55M465.44M
Stockholders Equity694.66M763.00M694.66M610.76M498.64M396.04M
Cash Flow
Free Cash Flow0.0019.10M-183.51M265.13M-58.80M-116.95M
Operating Cash Flow0.0038.05M-161.28M324.16M-58.73M-101.22M
Investing Cash Flow0.00-17.18M-14.82M-58.78M133.85K-15.28M
Financing Cash Flow0.00-16.83M175.52M-265.08M59.15M116.56M

M K Proteins Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.89
Price Trends
50DMA
5.09
Negative
100DMA
5.13
Negative
200DMA
5.85
Negative
Market Momentum
MACD
-0.09
Positive
RSI
33.32
Neutral
STOCH
24.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MKPL, the sentiment is Negative. The current price of 6.89 is above the 20-day moving average (MA) of 4.98, above the 50-day MA of 5.09, and above the 200-day MA of 5.85, indicating a bearish trend. The MACD of -0.09 indicates Positive momentum. The RSI at 33.32 is Neutral, neither overbought nor oversold. The STOCH value of 24.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MKPL.

M K Proteins Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
₹4.08B12.340.43%25.49%-8.35%
74
Outperform
₹68.06B18.6123.14%50.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
57
Neutral
₹1.31B14.5832.25%71.27%
54
Neutral
₹3.97B21.8117.36%24.73%
51
Neutral
₹1.77B26.2843.02%-18.82%
48
Neutral
₹6.34B13.1744.02%12.33%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:MKPL
M K Proteins Limited
4.72
-3.78
-44.47%
IN:GOKUL
Gokul Refoils & Solvent Ltd.
41.19
-4.97
-10.77%
IN:GOKULAGRO
Gokul Agro Resources Ltd.
232.90
90.62
63.69%
IN:KRITINUT
Kriti Nutrients Limited
81.35
-33.84
-29.38%
IN:MUKKA
Mukka Proteins Limited
22.75
-7.95
-25.90%
IN:ROML
Raj Oil Mills Limited
45.30
-15.01
-24.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 03, 2026